Previous Close | 6.75 |
Open | 6.75 |
Bid | 2.90 |
Ask | 5.70 |
Strike | 260.00 |
Expire Date | 2026-01-16 |
Day's Range | 6.75 - 6.75 |
Contract Range | N/A |
Volume | |
Open Interest | 1 |
Zoetis earnings and sales slightly beat first-quarter estimates for the pet drugmaker. Shares rose modestly.
PARSIPPANY, N.J., May 02, 2024--Zoetis Inc. (NYSE:ZTS) today reported its financial results for the first quarter of 2024 and updated its guidance for full year 2024.
The animal health firm has had a tough year with shares down nearly 20% amid negative media reports about a key new medicine.